Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy
Susanne B. Nicholas(University of California, Los Angeles), Willa A. Hsueh(The Ohio State University Wexner Medical Center), Alan R. Collins(University of California, Los Angeles), Nalini Govindarajan(University of California, Los Angeles), Elsa Aguiniga(University of California, Los Angeles), Wei Wang(Institute of Pharmacology), Jason Kim(University of California, Los Angeles), Masakuni Noda(University of California, Los Angeles), Joyce S. W. Wong(University of California, Los Angeles), Yuelan Ren(University of California, Los Angeles), Yasuko Kawano(Cal Poly Humboldt)
Cited by 154
Related Papers
Demographic history and rare allele sharing among human populations
|Proceedings of the National Academy of Sciences|2011|733
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|646
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
|Journal of Clinical Investigation|1996|479